2 Oct 2018 07:00
PRESS RELEASE
Sensyne Health plc
Change of registered office address
Oxford, UK; 01 October 2018: Sensyne Health plc (LSE: SENS), the British clinical AI technology company, today announces that it has changed its registered address with immediate effect to:
Schrödinger Building, Heatley Road, Oxford Science Park, Oxford, OX4 4GE.
-ENDS-
For more information please contact:
Sensyne Health (www.sensynehealth.com) | +44 (0) 330 058 1845 |
Lord (Paul) Drayson, Chief Executive Officer | |
Lorimer Headley, Chief Financial Officer | |
Laura Steward, Head of Marketing | |
Peel Hunt LLP (Nominated Adviser and Broker) | + 44 (0) 20 7418 8900 |
Dr Christopher Golden James Steel | |
Oliver Jackson | |
Consilium Strategic Communications | +44 20 3709 5700 |
Mary-Jane Elliott | |
Sukaina Virji | |
Melissa Gardiner | |
sensynehealth@consilium-comms.com |
About Sensyne Health
Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company's access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts. This is to ensure that the purpose of the anonymisation and the proposed analysis are subject to appropriate ethical oversight and information governance, including conformance with NHS principles and code of conduct, UK data protection law and applicable regulatory guidance.
Sensyne Health is quoted on the AIM Market of the London Stock Exchange (SENS.L).
For more information, please visit: www.sensynehealth.com
SENS.L (SENS)